Pfizer Looks Outside U.S. Despite New Tax Rules

The video discusses the impact of US efforts to restrict tax inversions, focusing on recent rules announced by Jack Lew. These rules aim to limit the benefits of inversions for American companies, though they leave core advantages largely intact. The discussion includes potential deals involving companies like Pfizer and Actavis, market reactions, and the strategic nature of these deals. The video also covers the implications of new rules on accessing offshore cash and the need for stronger congressional action to fully address inversion issues.

What is the significance of the term 'willing seller' in the context of corporate acquisitions?

Discuss the implications of Congress not taking strong action against inversions.